Roche’s Atezolizumab injection (Tecentriq) approved for subcutaneous use in India. • Approval requires Roche to conduct a Phase IV clinical trial. • Subcutaneou
Author: PharmaSignal News Desk
FDA launches a program to streamline the construction of drug manufacturing sites in the U.S., enhancing domestic production capabilities.